Highlights and Quick Summary
- Average Common Equity for the quarter ending March 31, 2023 was $6.12 Million (a -38.31% decrease compared to previous quarter)
- Year-over-year quarterly Average Common Equity decreased by -46.56%
- Annual Average Common Equity for 2022 was $2.88 Million (a -74.82% decrease from previous year)
- Annual Average Common Equity for 2022 was $11.4 Million (a -42.8% decrease from previous year)
- Annual Average Common Equity for 2021 was $20 Million (a 32.31% increase from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Common Equity of Benitec Biopharma Limited
Most recent Average Common Equityof BNTC including historical data for past 10 years.Interactive Chart of Average Common Equity of Benitec Biopharma Limited
Benitec Biopharma Limited Average Common Equity for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $6.12 | – | – | – | – |
| 2022 | $9.92 | $15.04 | $11.45 | $9.23 | $2.88 |
| 2021 | $12.73 | $11.61 | $15.12 | $11.63 | $20.01 |
| 2020 | $14.75 | $11.28 | $12.6 | $13.03 | $10.24 |
| 2019 | – | – | – | $16.41 | $16.59 |
| 2018 | – | – | – | – | $14.19 |
| 2017 | – | – | – | $17.24 | $16.35 |
| 2016 | – | $17.48 | $19.54 | $24.37 | $13.87 |
| 2015 | – | – | $10.15 | $17.48 | $25.4 |
| 2014 | – | – | $19.54 | $24.37 | $15.73 |
| 2013 | $10.15 | – | – | – | $15.73 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology